ArriVent BioPharma, Inc.

AVBP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.4B · 77 employees
40
SEC Filings
$26.73
Close 2026-05-22
77
Employees

Business Summary

PARTI Overview We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. We seek to utilize our teams deep drug development experience to maximize the potential of our lead product candidate, firmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, including ARR-217 (MRG007), through approval and ...

Latest Stock Quote

AVBP 2026-05-22 $26.73 O:$27.1 H:$27.685 L:$26.43 Vol:0.4M VWAP:$26.7672
origin leaf: d935516f71ee0eb61808c83f95ddbc30cb62d3d5b43618a86e2526e3e62dc393

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024127EDGAR116K words
2025-03-032024-12-310001558370-25-001999EDGAR—
2024-03-282023-12-310001558370-24-004280EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001104659-25-108847EDGAR20K words
2025-08-112025-06-300001558370-25-010975EDGAR—
2025-05-122025-03-310001558370-25-007276EDGAR—
2024-11-142024-09-300001558370-24-015624EDGAR—
2024-08-142024-06-300001558370-24-012236EDGAR—
2024-05-082024-03-310001558370-24-007197EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001104659-26-029588EDGAR1K words
2026-03-050001104659-26-024112EDGAR—
2025-11-100001104659-25-108839EDGAR—
2025-09-090001558370-25-011954EDGAR—
2025-08-110001558370-25-010974EDGAR—
2025-07-210001104659-25-069169EDGAR—
2025-07-020001104659-25-065386EDGAR—
2025-06-230001104659-25-061375EDGAR—
2025-06-200001104659-25-061165EDGAR—
2025-05-120001558370-25-007259EDGAR—

40 total filings indexed. 21 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001868279
TickerAVBP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.arrivent.com
Listed2024-01-26

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 66402d2d272c7b8357973bffa52ae959e36fbf54a5140f636896a51554edb3bf
parent: f162d7e914b4a68ef624524dc9b8a1b4f6e1820c53b80c801c638f00ef81b0ba
content hash: 73e8c7531f539db5b3fda896b61d7eec3f0907dc0902f9828a082ce58db71fdd
signed: 2026-06-02T19:00:18.732Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf